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Introduction
Parkinson’s disease is characterized by the selective degeneration 
of dopamine-producing neurons that comprise the substantia nigra 
pars compacta and the presence of proteinaceous inclusion bodies 
(Lewy bodies) in the affected neurons (Dawson and Dawson, 
2003). The principal component of Lewy bodies is α-synuclein 
(α-syn), which is an intrinsically unfolded protein of unknown 
function (Weinreb et al., 1996; Uversky et al., 2000). Wild-type 
(WT) α-syn and two mutants, A30P and A53T (Polymeropoulos 
et al., 1997; Kruger et al., 1998), associated with early onset PD 
have been linked to a plethora of defects, including proteasomal 
and mitochondrial dysfunction (Tanaka et al., 2001; Martin et al., 
2006), the accumulation of reactive oxygen species (ROS) (Xu 
et al., 2002), blockage of ER to Golgi traffi  c (Cooper et al., 2006), 
and histone acetylation inhibition (Kontopoulos et al., 2006).
Using a genetic screen that exploits the super sensitivity 
of  α-syn–expressing yeast cells to killing by H2O2 (Flower 
et al., 2005), we discovered that YGR198w, which is an essential 
gene of unknown function, suppresses the toxicity of the mutant 
α-syn A30P. Because humans have several possible YGR198w 
orthologues, understanding the function of this gene may shed 
light on how human neurons protect themselves from α-syn. 
Given that YGR198w codes for an α-synuclein protective protein, 
YGR198w was named YPP1.
Until quite recently, other than its deletion kills cells 
(Rodriguez-Pena et al., 1998), scant information existed about 
YPP1. A recent study using a technique to probe the spectrum of 
synthetic genetic interactions among essential genes revealed that 
YPP1 interacts genetically with ACT1, ARP2, SEC1, SEC15, and 
SEC18 (Davierwala et al., 2005). Other studies have indicated 
that YPP1 functions in MAPK pathways (Roberts et al., 2000; 
Hazbun et al., 2003; Mnaimneh et al., 2004). Ypp1p-GFP local-
izes in a punctate pattern around the plasma membrane (Huh 
et al., 2003), although there is no indication from its sequence 
that Ypp1p is a membrane protein. Although information exists 
about its synthetic genetic interactions and localization, Ypp1p’s 
function has remained obscure. Here, we show that Ypp1p binds 
A30P (but not WT or A53T) and mediates a sequence of events 
in which A30P is encapsulated into vesicles at the plasma mem-
brane, and the vesicles then transit to and merge with the vacuole, 
where the A30P protein is proteolytically degraded.
Results
A genetic screen identiﬁ  es YPP1 
as a suppressor of A30P toxicity
A high copy yeast genomic library was used to identify sup-
pressors of the super sensitivity of A30P expressing cells to 
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sing a genetic screen we discovered that YGR198w 
(named YPP1), which is an essential Saccharomyces 
cerevisiae gene of unknown function, suppresses 
the toxicity of an α-synuclein (α-syn) mutant (A30P) that is 
associated with early onset Parkinson’s disease. Here, we 
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wild-type α-syn or the A53T mutant. The Ypp1 protein, 
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A30P-containing vesicles trafﬁ  ck to and merge with the 
vacuole, where A30P is proteolytically degraded. We 
show that Ypp1p binds to A30P but not the other two 
α-syns; that YPP1 interacts with genes involved in endo-
cytosis/actin dynamics (SLA1, SLA2, and END3), protein 
sorting (class E vps), and vesicle-vacuole fusion (MON1 
and CCZ1) to dispose of A30P; and that YPP1 also partic-
ipates in pheromone-triggered receptor-mediated endo-
cytosis. Our data reveal that YPP1 mediates the trafﬁ  cking 
of A30P to the vacuole via the endocytic pathway.
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killing by hydrogen peroxide (Fig. 1 A). Herein, we describe 
the characterization of one suppressor, YPP1, which is an es-
sential gene of unknown function. Table I gives the strains and 
plasmids used in this study.
YPP1 codes for a protein with a theoretical molecular mass 
of 95.4 kD. Cells expressing α-syn and transformed with a plas-
mid harboring a myc-tagged YPP1 fusion indeed expressed myc-
Ypp1p, as judged by Western blot analysis and staining with an 
anti-myc antibody (Fig. 1 B). Specifi  cally, myc-Ypp1p was de-
tected in cells that coexpressed WT α-syn or A30P (lanes 2 and 4); 
however, in each case, a ladder of bands ranging from 95 to 
>200 kD was observed. We attribute the band at 95 kD to myc-
Ypp1p and suggest that the bands at higher molecular mass are 
posttranslationally modifi  ed forms of Ypp1p. The four major 
bands of myc-tagged Ypp1p were absent in lysates of cells that 
did not harbor the MYC-YPP1 plasmid (lanes 1 and 3).
The effect of Ypp1p overexpression on the viability of cells 
expressing the various α-syns was also evaluated. A viability 
assay (Fannjiang et al., 2004) was conducted using the dye FUN1 
on cells induced for 12 h. Dead cells stained green; metabolically 
active, and hence viable cells, stained red; and a small percentage 
of cells ( 10%) failed to stain. The percentage of red cells indi-
cated viability. For cells expressing A30P with Ypp1p over-
expression, 90% of the cells were viable, whereas only 10% of 
cells were viable when A30P was expressed without Ypp1p over-
expression (Fig. 1, C and D). In contrast, for cells expressing WT 
α-syn or A53T, with or without Ypp1p overexpression, only 
 10% of the cells were viable (Fig. 1 D). This viability assay 
demonstrated that YPP1 in high copy specifi  cally enhances the 
viability of A30P expressing cells but not of cells expressing the 
other two α-syns (WT or A53T).
YPP1 suppresses ROS accumulation 
in A30P expressing cells
A signature feature of α-syn is that it induces oxidative stress in 
various types of cells (Xu et al., 2002; Flower et al., 2005; Smith 
et al., 2005). Given that YPP1 in high copy suppresses the super 
sensitivity of A30P expressing cells to killing by hydrogen per-
oxide, we expected that Ypp1p overexpression would abolish 
ROS production in A30P expressing yeast cells (Flower et al., 
2005), but not in cells expressing WT or A53T α-syn. To test 
this hypothesis, cells expressing α-syn (WT, A30P, or A53T) 
with decreased, endogenous, or increased levels of Ypp1p were 
stained with the cell-permeant dye DHR 123. This dye enters 
cells, and when oxidized by free radicals yields a fl  uorescent 
product (Schulz et al., 1996). For these experiments a strain from 
the “Hughes collection” of titratable promoter alleles was used 
(Mnaimneh et al., 2004) in which a kan
R-tetO7-TATA cassette 
is integrated into the promoter of YPP1. Repression is con-
trolled by adding doxycycline, which has no appreciable effect 
on global gene expression at the concentrations (20 μg/ml) used 
for the promoter shut off.
Fig. 2 (A–C) shows ROS accumulation in cells expressing 
WT α-syn, A30P, or empty vector controls. ROS accumulation 
in cells expressing WT α-syn (or A53T) was insensitive to varia-
tions in the level of Ypp1p (compare the three vertical panels 
Figure 1. Identiﬁ  cation of YPP1 as a suppres-
sor of A30P 𝗂-syn toxicity. Suppression of 
A30P toxicity by a high-copy yeast genomic 
  library. FY23 cells transformed with pTF202 
(A30P) and plated on SGal–Trp (left plate). 
FY23 cells transformed with pTF202 (A30P) 
and a 2-μm yeast genomic library and plated 
on SGal–Trp–Leu (right plate). 2-d incubation 
at 30°C. The disk in the center of each plate 
contained 10 μl of  8% hydrogen peroxide. 
(B) Western blot analysis of cells expressing 
α-syn with or without myc-Ypp1p overexpression. 
FY23 cells transformed with pTF201 (WT α-syn), 
pTF202 (A30P), or pTF203 (A53T) and pTF504 
(myc-Ypp1) or pTF503 (empty vector) were 
pregrown in noninducing media to mod-log 
phase, shifted to inducing media, and incu-
bated for 3 h at 30°C. Cell extracts were 
  prepared and subjected to SDS-PAGE and 
  immunoblotting. The proteins were visualized us-
ing monoclonal antibodies (anti-α-syn; anti-myc). 
Lane 1, WT α-syn; lane 2, myc-Ypp1p and WT 
α-syn; lane 3, A30P; lane 4, myc-Ypp1p and 
A30P. (C) Effect of Ypp1p overexpression on 
cell viability after 12 h of induction. The FUN1 
dye stains metabolically active cells red and 
dead cells green. The top panel shows that 
cells expressing A30P (plus plasmid with no 
insert) are dead (green). The bottom panel shows 
that cells expressing A30P with Ypp1p over-
expression are viable (red). The FY23 strain, 
harboring pTF302 (A30P) and pTF602 (YPP1) 
or pTF604 (empty vector), was used in these 
  experiments. (D) Plot of percent viability (mean ± 
SD). The number of cells counted for each group 
was n = 400 to 1,400. *, P = 0.000013.SUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1093
  labeled DHR in Fig. 2 A). In contrast, ROS accumulation in cells 
expressing A30P was exquisitively sensitive to the level of 
Ypp1p: 100% of the cells exhibited intense red fl  uorescence 
when the level of Ypp1p was decreased (+doxy), whereas only 
 5% of the cells exhibited red fl  uorescence when Ypp1p was 
overexpressed (compare the three vertical panels labeled DHR in 
Fig. 2 B). Identically treated control cells harboring the plasmid 
with no insert exhibited no appreciable ROS accumulation 
(Fig. 2 C). These experiments revealed that Ypp1p, when over-
expressed, abolished ROS accumulation in cells expressing 
A30P—but not in cells expressing WT α-syn or A53T (Fig. 2 D).
Ypp1p binds to A30P—but not to WT 
or A53T
Coimmunoprecipitation experiments were performed to deter-
mine whether Ypp1p physically associated with A30P. Coimmuno-
precipitations of cells overexpressing Ypp1p with WT α-syn, 
A30P, or A53T coexpressed are shown in Fig. 2 E (lanes 1–6). 
For each sample, one lane contained the lysate and the other lane 
contained the myc-Ypp1p pull down. The myc-Ypp1p ( 95-kD 
band) was visualized with an anti-myc antibody and the α-syns 
( 19 kD) with an anti-α-syn antibody. A comparison of the two 
blots showed that Ypp1p pulled down A30P (lane 4), but not WT 
α-syn or A53T (lanes 2 and 6). The experiments revealed that, 
when overexpressed, Ypp1p associates with A30P.
We also found that in high copy YPP1 permitted normal 
growth of cells expressing A30P but not of cells expressing WT 
or A53T (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200610071/DC1), and that in high copy YPP1 failed 
to protect yeast cells from hydrogen peroxide-induced ROS 
(Fig. S2). YPP1 is thus unlikely to code for an enzyme that in-
activates hydrogen peroxide.
Ypp1p alters GFP-𝗂-syn localization
To gain insight into the mechanism of suppression, fl  uorescence 
microscopy studies were conducted to determine the effect of 
Figure 2.  YPP1 suppresses ROS accumulation in 
A30P expressing cells. ROS accumulation in cells 
expressing A30P (pTF302) (A), WT α-syn (pTF301) 
(B), or vector control cells (pTF300) (C). The “Hughes” 
YPP1 strain that contains a titratable promoter was 
used in these experiments. This strain transformed with 
pTF602 (YPP1) or pTF604 (empty vector) was used for 
these experiments. For shutting off YPP1 (+doxy), cells 
were pregrown in noninducing media with 20 μM 
doxycycline for 7 h, and then shifted into inducing 
media with doxycycline. For experiments with Ypp1p 
overexpression, cells were pregrown in noninducing 
media to mid-log, and then shifted into inducing me-
dia. The images shown in all panels were obtained at 
3 h in inducing media. The dye DHR123 was added 
after 2 h in inducing media to give 5 μg/ml, and the 
cells were then washed before image acquisition. 
DHR, rhodamine 123. DIC, differential interference 
contrast. (D) Plot of the percentage of cells that exhib-
ited red ﬂ  uorescence  (mean  ± SD). The number of 
cells counted for each group was n = 640 to 1,200. 
The symbols “−“, “e”, and “+” indicate decreased 
(with doxycycline), endogenous, and increased levels 
of Ypp1p, respectively. (E) Coimmunoprecipitation 
shows selective binding of myc-Ypp1p to A30P. Cells 
expressing the various α-syns and overexpressing 
myc-tagged Ypp1p were lysed, the extract was incu-
bated with an anti-myc antibody-protein A resin, and 
the resin was boiled and reduced and subjected to 
SDS-PAGE and immunoblotting. The top panels show 
the  95-kD band due to myc-Ypp1p; the bottom 
  panels show α-syn. Lane 1, WT α-syn lysate; lane 2, 
myc-Ypp1p fails to pull down WT α-syn; lane 3, A30P 
lysate; lane 4, myc-Ypp1p pulls down A30P; lane 5, 
A53T lysate; lane 6, myc-Ypp1p fails to pull down 
A53T. The FY23 strain was transformed with pTF201 
(WT α-syn), pTF202 (A30P), or pTF203 (A53T) and 
with pTF504 (myc-YPP1) or pTF503 (empty vector).JCB • VOLUME 177 • NUMBER 6 • 2007  1094
Ypp1p overexpression on the localization of the various GFP-
tagged α-syns. We found that Ypp1p overexpression altered the 
localization of each of the three GFP-tagged α-syns (WT, A30P, 
or A53T), but in subtly distinct ways compared with control 
cells without Ypp1p overexpression (Fig. 3, A–C). For exam-
ple, cells expressing GFP-A30P with Ypp1p overexpression 
exhibited 3 to 6 inclusions per cell at 3 h of induction, whereas 
at 12 h the inclusions had coalesced into 1 to 2 larger inclusions 
(Fig. 3 A). Without Ypp1p overexpression, GFP-A30P expressing 
cells exhibited diffuse green fl  uorescence at 3 and 12 h. In con-
trast, Ypp1p, when overexpressed, even drove GFP-WT α-syn and 
GFP-A53T from the plasma membrane into inclusions, but in 
each case the inclusions failed to effi  ciently merge with one 
  another (Fig. 3, B and C). Notice that control cells expressing 
GFP exhibited diffuse green fl  uorescence that was unaffected by 
increased levels of Ypp1p (Fig. 3 D). The experiments revealed 
that Ypp1p when overexpressed drives the various α-syns into 
inclusions. That Ypp1p concentrated GFP-A30P into 1 to 2 
inclusions per cell raised the possibility that Ypp1p also drives 
A30P into a compartment such as the vacuole.
Ypp1p drives A30P to the vacuole
To test the hypothesis that Ypp1p drives A30P to the lysosome/
vacuole, two-color fl  uorescence microscopy experiments were 
conducted using cells expressing the various GFP-tagged α-syns 
and the lipophilic dye FM4-64, which stains vacuoles (Vida and 
Emr, 1995). At various times (3 or 12 h) after induction, cells 
 expressing  GFP-α-syn were incubated with the FM4-64 dye and 
microscopy images were acquired (Fig. 4 A). If GFP-α-syn en-
ters the vacuole then the green fl  uorescence from GFP and the red 
fl  uorescence from FM4-64 should overlap. No overlap between 
any of the GFP-α-syn inclusions with the red structures occurred 
after 3 h of induction, whereas almost every one of the GFP-
A30P inclusions overlapped with the red structures after 12 h of 
induction. No such overlap occurred for GFP-WT α-syn or GFP-
A53T structures with vacuoles. However, because vacuoles were 
not prominent in the DIC images (12 h), these experiments do not 
prove that Ypp1p drove A30P into the vacuole. For this reason, 
the following biochemical analysis was conducted.
Ypp1p-mediated transport of A30P to the vacuole was 
tested using Western blot analysis to monitor the level of the 
A30P protein. Cells transformed with the various plasmids were 
pregrown in noninducing media to mid-log phase, shifted to 
  inducing media, inhibited with 10 μM cycloheximide to halt 
protein synthesis, and incubated for 12 h. Aliquots were removed 
at the indicated times and extracts were prepared, subjected to 
SDS-PAGE followed by Western blot analysis. First, we found 
that A30P was rapidly degraded (t1/2  1 h) in cells overexpressing 
Ypp1p (Fig. 4 B i, and C), whereas in cells expressing A30P, 
but with no Ypp1p overexpression, no such degradation of 
A30P occurred (Fig. 4 B ii, and C). Second, if A30P is degraded 
in the vacuole, then A30P should fail to be degraded in a strain 
that lacks PEP4, which is a gene that codes for a protease that 
activates a variety of vacuolar proteases (Jones et al., 1982). To 
test this hypothesis, the level of A30P was monitored in a ∆pep4 
deletion strain, and the A30P protein showed no appreciable 
degradation in this strain (Fig. 4 B iii, and C). Third, to rule out the 
possibility that Ypp1p mediates the proteasomal degradation of 
A30P, experiments were also conducted using the proteasome 
inhibitor MG132 (50 μM). With protein synthesis inhibited and 
with proteasome function inhibited A30P was still degraded 
(Fig. 4 B iv, and C), albeit not with the exact kinetics as observed 
when only cycloheximide was used. The ability of the pep4 
deletion to halt A30P degradation, combined with the lack of 
appreciable inhibition of A30P degradation by a proteasome 
inhibitor, indicated that Ypp1p mediates the transport of A30P 
to the vacuole, where it is proteolytically degraded.
Ultra structural analysis
Transmission electron microscopy was conducted to gain in-
sight into the nature of the α-syn inclusions in +A30P/+Ypp1 
cells. A30P expression induced dramatic morphological changes 
in cells at only 3 h of induction compared with control cells 
(Fig. 5 A). Changes included granulation of the cytosol and 
chromatin condensation. In contrast, control cells containing 
two empty plasmids (−A30P/−Ypp1) had a well-delineated 
vacuole and cytoplasm. Cells expressing A30P with Ypp1p 
overexpressed exhibited smaller vacuoles than cells with the 
two empty plasmids and had numerous mitochondria per slice. 
Vesicles budding off of the plasma membrane were also ob-
served in these cells. These vesicles were absent in cells ex-
pressing only A30P. Such a vesicle can be seen in the bottom 
left image in Fig. 5 A (denoted by the white arrow). At higher 
magnifi  cation the vesicle appears to be emerging from the plasma 
membrane (Fig. 5 B).
After 12 h of induction, cells expressing only A30P were 
characterized by a granulated cytosol and even more extensive 
chromatin condensation compared with 3 h induction. Comparing 
Figure 3.  Ypp1p alters GFP-𝗂-syn localization. The effect of Ypp1p 
overexpression on the localization of (A) GFP-A30P, (B) GFP-WT α-syn, 
(C) GFP-A53T, and (D) GFP at 3 and 12 h of induction. In each group of four 
panels, the top and bottom rows are of cells expressing GFP-α-syn with and 
without Ypp1p overexpressed, respectively. S288c cells were transformed 
with pTF305 (WT α-syn), pTF306 (A30P), pTF307 (A53T), or pTF308 
(GFP) and pTF602 (YPP1) or pTF604 (empty vector). Bar, 5 μm.SUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1095
this TEM image to the images of the −A30P/−Ypp1 control cells 
and +A30P/+Ypp1 cells revealed the following differences: 
(1) control cells with two empty plasmids exhibited a granu-
lated cytosol and chromatin condensation (Fig. 5 A). These 
changes did not occur when the strain was incubated in glucose 
or sucrose for 12 h. The changes occurred because of the abrupt 
shift from sucrose to galactose. It turns out that the wt S288c 
strain, but not the Resgen deletion collection, which is derived 
from the S288c strain, has a mutation in GAL2. After  15 gen-
erations WT S288c cells begin to lose viability. Using the FUN1 
assay we found that 90% and 60% of the WT S288c cells were 
viable after 3 h and 12 h in galactose (unpublished data), 
respectively. It should be pointed out that YPP1 in high copy 
suppressed A30P-induced ROS at 12 h in strains FY23, S288c, 
and various S288c gene deletion strains. (2) The +A30P/+Ypp1 
cells were characterized by a normal nucleus, numerous mito-
chondria per optical slice, and three large vacuoles (denoted 
by white arrows; Fig. 5 A). More than 90% of the EM sections 
examined contained such vacuoles.
Immunogold labeling was also performed to visualize the 
subcellular location of A30P. Cells expressing A30P and over-
expressing Ypp1p were characterized by numerous clusters of gold 
particles in association with the plasma membrane (Fig. 5 C). In 
contrast, cells expressing A30P only, or harboring the two control 
plasmids, did not have gold particles in association with the plasma 
membrane. Therefore, we attributed the membrane-associated 
clusters to A30P molecules that were being packaged by Ypp1p 
into endocytic vesicles. Note that the membrane-associated clusters 
are smaller than the budding vesicle (compare Fig. 5, B and C); 
this could be because of the diffi  culty of preserving membrane 
structure for immunogold labeling and also because only a small 
portion of a vesicle contains A30P. Clusters of gold particles 
were also evident inside the cells (Fig. 5 D). The TEM results 
showed that YPP1 in high copy protects cells from A30P.
Genes that interact with YPP1
To begin to defi  ne the pathway by which YPP1 suppresses A30P 
toxicity, a targeted screen of 116 nonessential genes involved in 
Figure 4.  Ypp1p drives A30P to the vacuole. 
(A) Two-color ﬂ  uorescence microscopy experi-
ments of cells expressing GFP-α-syn with Ypp1p 
overexpression. S288c cells transformed with 
pTF305 (WT α-syn), pTF306 (A30P), pTF307 
(A53T), or pTF308 (empty vector) and pTF602 
(YPP1) or pTF604 (empty vector) were pre-
grown in noninducing media to mid-log phase, 
transferred to inducing media, and induced for 
3 or 12 h. Before the analysis cells were 
stained with the dye FM4-64. Aliquots were 
removed, washed, resuspended in YPD, and 
incubated with 40 μM FM4-64 for 10 min at 
30°C. Cells were then washed twice, re-
suspended in YPD, incubated an additional 30 
min at 30°C, and then visualized by ﬂ  uores-
cence microscopy. The white arrows (top right-
hand panel, GFP-A30P) indicate areas of 
overlap between the GFP inclusions with the 
red structures. Bar, 5 μm. (B) Ypp1p promotes 
degradation of A30P. Western blot analysis 
was conducted to monitor the level of A30P in 
cells. Blots (i and ii): Ypp1p overexpression. 
10 μM cycloheximide was used to halt protein 
synthesis in cells with (i) or without (ii) Ypp1p 
overexpression. S288c cells transformed with 
pTF202 (A30P) and pTF602 (YPP1) or pTF604 
(empty vector) were pregrown in noninducing 
media to mid-log phase, transferred to induc-
ing media, inhibited with cycloheximide, and 
induced for 12 h. Indicated times are after ad-
dition of cycloheximide. Blot (iii): Deletion of 
PEP4. A ∆pep4 deletion strain transformed 
with pTF202 (A30P) and pTF602 (YPP1) was 
pregrown in noninducing media to mid-log 
phase, transferred to inducing media, inhib-
ited with 10 μM cycloheximide, and induced 
for 12 h. Indicated times are after addition of 
cycloheximide. Blot (iv): Proteasome inhibition. 
S288c cells transformed with pTF202 (A30P) 
and pTF602 (YPP1) were pregrown in non-
inducing media to mid-log phase, transferred 
to inducing media, inhibited with 10 μM cyclo-
heximide and 50 μM of MG132, and induced for 12 h. Indicated times are after addition of inhibitors. For each experiment, cell extracts were prepared, 
subjected to SDS-PAGE, and immunoblotted using a monoclonal antibody speciﬁ  c for α-syn. In each blot, 20 μg of protein was loaded per well. Experiments 
were conducted two or three times. (C) Degradation of A30P. Band intensities in the blots were determined using a scanner with image quantization 
software and plotted against time. (i) Blue, A30P + Ypp1p overexpression; (ii) red, A30P + endogenous level of Ypp1p; (iii) green, A30P + Ypp1p over-
expression in ∆pep4 strain; (iv) yellow, A30P + Ypp1 overexpression + 50 μM MG132.JCB • VOLUME 177 • NUMBER 6 • 2007  1096
autophagy, cytosol-to-vacuole transport (Cvt), endocytosis, and 
the vacuole protein sorting pathway (vps) was conducted (Fig. 6 
and Table S1 for entire list, available at http://www.jcb.org/cgi/
content/full/jcb.200610071/DC1). We reasoned that any gene that 
cooperates with YPP1 to protect against A30P, when deleted, 
should increase ROS accumulation. The ROS assay using the 
DHR 123 dye was conducted in 96-well plates on cells induced 
for 3 h using a plate reader with fl  uorescence detection. The 
various deletion strains were transformed with the pTF302 (A30P) 
and pTF602 (YPP1) plasmids.
The vacuolar protein sorting pathway (vps) is a network 
of genes involved in the transport of newly synthesized proteins 
from the late Golgi to the vacuole (Bowers and Stevens, 2005). 
56 VPS deletion strains were analyzed, and of these 56 strains 
16 gave statistically signifi  cant increases in ROS (Fig. 6). Curi-
ously, 11 of the 16 hits clustered in the class E VPS genes. Many 
of the class E VPS genes code for ESCRT (Hurley and Emr, 
2006) proteins that function to sort membrane-bound proteins 
into lumenal multivesicular body vesicles (MVB). Our inter-
pretation of these fi  ndings is that the deletion of certain class E 
genes resulted in the failure of A30P to be sorted into lumenal 
MVB vesicles, and this prevented A30P from being delivered 
to and degraded within the vacuole. Failure to degrade A30P 
resulted in the accumulation of ROS.
Data obtained from selected deletion strains associated 
with actin organization, autophagy, Cvt, endocytosis, vacuolar 
biogenesis, and vesicle–vacuole fusion, are presented in Fig. 6 
and Table S1. First, fi  ve deletion strains gave very large 
(>200,000 units; P < 0.001) increases in ROS compared with 
the WT control (25,818 ± 7005 units) (Fig. 6). These fi  ve strains 
were: ∆sla1, ∆sla2, ∆end3, ∆mon1, and ∆ccz1. Sla1, Sla2, and 
End3 proteins form a complex on the lumenal side of the plasma 
membrane (Holtzman et al., 1993; Raths et al., 1993), where 
they regulate actin dynamics and proteins required for endocytosis 
(Toshima et al., 2006). The Ccz1p–Mon1p complex is required 
for nearly all membrane-traffi  cking pathways where the terminal 
acceptor compartment is the vacuole (Wang et al., 2002). Second, 
six deletion strains gave large (>100,000 units; P < 0.001) in-
creases in ROS compared with the WT control (Fig. 6). These 
strains were: ∆rvs161, ∆siw14, ∆snc1, ∆trx1, ∆vta1, and ∆vtc1. 
In general, these genes have roles in vesicle traffi  cking and actin 
fi  lament organization. Third, eleven genes involved in the auto-
phagy and Cvt pathways, when deleted, failed to increase ROS 
(Table S1). The broad picture that emerged from this screen was 
that YPP1 suppressed A30P toxicity via a pathway involving 
SLA1, SLA2, and END3, class E VPS genes, and MON1 and 
CCZ1. Given that these genes are involved in endocytosis and 
vesicle traffi  cking to the vacuole, such a fi  nding, together with 
the fl  uorescence and TEM data (Figs. 3–5), indicate a role for 
YPP1 in the endocytic pathway.
Latrunculin A, a known inhibitor of actin (Ayscough et al., 
1997), disrupts the trafficking of endosomal vesicles from 
Figure 5.  Transmission electron microscopy images of 
cells expressing Ypp1p and A30P. (A) S288c cells trans-
formed with pTF302 (A30P) or pTF300 (empty vector) 
and pTF602 (YPP1) or pTF604 (empty vector) were pre-
grown in noninducing media to mid-log phase, transferred 
to inducing media and induced for 3 or 12 h. Top: 
−A30P/−Ypp1 (cells contained two plasmids with no 
  inserts). Middle: +A30P/−Ypp1 (cells contained two plas-
mids, one with no insert). Bottom: +A30P/+Ypp1 (cells 
contained two plasmids). Bars, 1 μm. (B) Magniﬁ  cation of 
+A30P/+Ypp1 cell at 3 h shows vesicle budding from 
the plasma membrane. (C and D) Immunogold labeling of 
cells expressing A30P and overexpressing Ypp1p at 12 h. 
A secondary antibody conjugated with 50-nm gold parti-
cles was used to detect A30P. Several clusters of gold par-
ticles occurred in the vicinity of the plasma membrane (C) 
and also in the interior of cells (D).SUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1097
the plasma membrane to the vacuole (Toshima et al., 2006). 
Latrunculin A (25 μM)–treated cells expressing A30P and 
overexpressing Ypp1p indeed exhibited a large increase in ROS 
signal (284,979 ± 10,816) compared with identically treated 
cells that lacked latrunculin A (25,818 ± 7005) (Fig. 6). Our 
interpretation of this result is that latrunculin A inhibits the 
formation of actin fi  laments which in turn blocks the budding 
of endocytic vesicles containing A30P and delivery of A30P to 
the vacuole.
Mechanism of YPP1 suppression
To verify results obtained from the ROS plate reader assay, the 
∆mon1 and ∆sla1 strains were selected for further analysis. The 
S288c control strain expressing GFP-A30P and overexpressing 
Ypp1p exhibited 4 to 5 inclusions per cell at 3 h, and these 
inclusions had coalesced into 1 to 3 inclusions per cell at 12 h 
(Fig. 7 A). The ∆mon1 strain expressing GFP-A30P and over-
expressing Ypp1p also exhibited 4 to 5 inclusions per cell 
at 3 h (Fig. 7 B), but at 12 h multiple inclusions per cell were 
Figure 6.  Screening for genes that interact withYPP1. The indicated deletion strains transformed with pTF302 (A30P) and pTF602 (YPP1) were pregrown 
in noninducing media to mid-log phase, transferred to inducing media, and induced for 3 h. Matched controls consisted of identically treated S288c cells 
transformed with the same two plasmids. The dye DHR 123 was added at 2 h after induction. After several washing steps, cells were aliquoted into 96-well 
plates and the DHR 123 ﬂ  uorescent product was detected using a plate reader. Cells incubated in dilute acetic acid exhibit ROS (Ludovico et al., 2002), 
and this served as a positive control. Latrunculin A was used at 25 μM. Experiments were performed in two to ﬁ  ve independent experiments, each in tripli-
cate. Bars indicate mean ROS signal ± SD. Comparing each deletion strain to matched controls (S288c +A30P/+Ypp1) yielded P-values: red, P < 0.001; 
orange, P < 0.05; and blue, P > 0.05. Exact P values are given in Table S1 (available at http://www.jcb.org/cgi/content/full/jcb.200610071/DC1).JCB • VOLUME 177 • NUMBER 6 • 2007  1098
still evident. Given its role in catalyzing the fusion of vesicles 
with the vacuole (Wang et al., 2002), deletion of MON1 would 
be expected to hinder fusion of A30P-containing vesicles with 
the vacuole, and the microscopy images are consistent with 
such a defect. Notice that adding back MON1 on a plasmid res-
cued the inability of vesicles to coalesce at 12 h in the ∆mon1 
strain (Fig. 7 C). These experiments confi  rmed that MON1 is 
involved in the pathway by which YPP1 rids cells of A30P.
The effect of the ∆sla1 deletion on Ypp1p-mediated 
traffi  cking of GFP-A30P was also analyzed. After 3 or 12 h of 
induction ∆sla1 cells expressing GFP-A30P and overexpressing 
Ypp1p displayed green fl  uorescence throughout the cell (Fig. 7 D). 
These images are very different from the images acquired from 
the S288c and ∆mon1 strains. Our interpretation of the ∆sla1 
images is that deletion of SLA1 prevents the packaging of GFP-
A30P into vesicles. Notice that adding back SLA1 on a plasmid 
resulted in the formation of  0–3 inclusions per cell after 3 h of 
induction; whereas, after 12 h of induction the inclusions had 
coalesced yielding 1–2 inclusions per cell (Fig. 7 E). These 
images from 12 h are remarkably similar to the images obtained 
at 12 h from the WT strain. Accordingly, we concluded that 
deletion of SLA1 resulted in a failure of cells to package A30P 
into vesicles.
An issue is whether A30P transits to the vacuole via the 
endocytic pathway, as proposed, or the secretory pathway. ER 
stress occurs when unfolded proteins accumulate in the ER, and 
such proteins are typically retrotranslocated out of the ER to the 
proteasome for degradation; this process is called ERAD (endo-
plasmic reticulum–associated degradation) (Meusser et al., 
2005). YPP1 does not facilitate retrotranslocation and ERAD 
because A30P was still degraded when the proteasome was in-
hibited (Fig. 4, B and C). However, yeast have another pathway 
for the degradation of soluble, unfolded proteins that transit 
through the ER and Golgi, and this occurs via receptor-mediated 
forward transport of unfolded luminal proteins to the vacuole 
(Hong et al., 1996). The receptor for this process is coded for 
by VPS10. Because deletion of VPS10 caused intense ROS ac-
cumulation in cells expressing A30P (Fig. 6), perhaps YPP1 is 
an enhancer of the forward transport of luminal proteins to the 
vacuole. On the other hand, although WT α-syn and A53T use 
the secretory pathway and cause ER stress (Cooper et al., 2006), 
such fi  ndings have not been reported for A30P. Instead, evidence 
exists that A30P does not use the secretory pathway (Dixon 
et al., 2005).
We examined whether loss of function of one early-acting 
and two late-acting SEC genes, i.e., SEC12, SEC1, and SEC5, 
respectively, affected YPP1-mediated traffi  cking of A30P to 
the vacuole. Sec12p controls transport vesicle budding from the 
ER (Barlowe and Schekman, 1993). Sec1p controls the fusion 
of secretory vesicles with the plasma membrane (Wiederkehr 
et al., 2004), and when exocytosis is shut down actin regulation 
also becomes disrupted (Aronov and Gerst, 2004). The Sec5 
protein is a component of the essential exocyst complex, which 
tethers secretory vesicles to the plasma membrane (TerBush 
et al., 1996). If YPP1 mediates A30P traffi  cking through the 
ER-Golgi to the vacuole, then this traffi  cking should be dis-
rupted in the sec12 but not in the sec1 or sec5 strains. Conversely, 
if YPP1 mediates A30P traffi  cking to the vacuole via endo-
cytosis, then this traffi  cking should be disrupted in the sec1 
and sec5 but not in the sec12 strains. The Hughes collection of 
titratable promoter alleles (Mnaimneh et al., 2004) was used in 
these experiments.
Decreasing the level of the essential Sec12 protein had 
no appreciable effect on YPP1-mediated traffi  cking of A30P to 
the vacuole. Specifi  cally, cells expressing GFP-A30P and over-
expressing Ypp1p, but with a decreased level of Sec12p, exhibited 
1–2 large GFP-A30P inclusions per cell, which coincided with 
the vacuole (Fig. 7 F). In contrast, decreasing the level of the 
Figure 7.  Effects of gene deletions on YPP1-mediated A30P trafﬁ  cking. 
The S288c strain and the two deletion strains transformed with pTF306 
(GFP-A30P) and pTF602 (YPP1) were pregrown in noninducing media to 
mid-log phase, transferred to inducing media, induced for 3 or 12 h, and 
then visualized by ﬂ  uorescence microscopy. The SEC1 and SEC12 Hughes 
strains transformed with pTF306 (GFP-A30P) and pTF602 (YPP1) were pre-
grown in noninducing media with doxycycline (20 μg/ml) for 7 h, trans-
ferred to inducing media with doxycycline, and then visualized at 3 and 
12 h by ﬂ  uorescence microscopy. (A) S288c; (B) ∆mon1; (C) ∆mon1 and 
pTF700 (MON1); (D) ∆sla1; (E) ∆sla1 and pTF701 (SLA1); (F) tet-SEC12 
strain + doxycycline; and (G) tet-SEC1 strain + doxycycline. (A–E): Im-
ages labeled “MERGE” had brightness and contrast adjustments of −12 
and +20, respectively. (F and G): images labeled MERGE had brightness 
and contrast adjustments of +40 and +20, respectively. Bar, 5 μm.SUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1099
essential Sec1 protein abolished YPP1-mediated traffi  cking of 
A30P to the vacuole. Specifi  cally, cells expressing GFP-A30P 
and overexpressing Ypp1p, but with a decreased level of Sec1p, 
exhibited no GFP-A30P inclusions after 3 or 12 h of induction 
(Fig. 7 G). Similar results were obtained for cells with a decreased 
level of the Sec5 protein (unpublished data). Because decreasing 
the level of Sec1p, or Sec5p, or deleting SLA1 eliminated YPP1-
mediated transport of A30P to the vacuole, we concluded that 
YPP1 mediates the traffi  cking of A30P to the vacuole via the 
endocytic pathway.
YPP1 participates in receptor-mediated 
endocytosis
Several reports have indicated that YPP1 functions in a MAPK 
pathway (Roberts et al., 2000; Hazbun et al., 2003; Mnaimneh 
et al., 2004). Because the yeast mating response is a MAPK 
pathway (Schwartz and Madhani, 2004) that involves receptor-
mediated endocytosis (RME), we asked whether YPP1 functions 
in the yeast mating response (Engqvist-Goldstein and Drubin, 
2003). In yeast, the response to pheromone is a well character-
ized example of RME: α-factor pheromone binds to Ste2p (on 
Mata cells) and triggers a sequence of events in which Ste2p and 
the α-factor are encapsulated into endosomes, which then transit 
along actin cables to the vacuole, where the pheromone and its 
receptor are proteolytically degraded (Dohlman, 2002). The hypo-
thesis that YPP1 participates in RME was tested by incubating 
α-factor with a Mata haploid strain containing an integrated 
YPP1-GFP allele replacing the WT allele (Table I).
The Mata haploid strain expressing Ypp1p-GFP exhibited 
no change in the localization of Ypp1p-GFP upon incubation 
for 20 min, and no change in localization was detected even 
  after hours of incubation. Weak, diffuse green fl  uorescence 
  occurred throughout the cytosol in these cells, and somewhat 
more brightly fl  uorescent puncta appeared around the periphery 
of the cells (Fig. 8 A). The enhanced staining around the pe-
riphery was consistent with Ypp1p-GFP associating with actin 
cortical patches, which are thought to be the sites of exocytosis 
and endocytosis. In contrast, treatment of this strain with 
α-factor resulted in a rapid change in the localization of Ypp1p-
GFP and a parallel increase in the fl  uorescence signal (Fig. 8 A). 
Cells exhibited numerous vesicles that appeared to coalesce 
into larger structures after 20 min. The green inclusions of 
Ypp1p-GFP merged with the vacuolar structures in the DIC 
  images. These experiments showed that the endosomes formed 
in response to pheromone contained Ypp1p-GFP, and that such 
Ypp1p-GFP–containing endosomes then merged with the vacuole. 
This data strongly supported our conclusion that Ypp1p is in-
volved in endocytosis.
Intrigued by the ability of pheromone to drive Ypp1p into 
vesicles, the hypothesis that pheromone itself could protect 
cells from the toxicity of the A30P protein—by driving A30P 
into endosomes, which then traffi  c to the vacuole, where A30P 
is degraded—was tested. The experiment was conducted by 
transforming the FY23 Mata haploid strain with plasmids for 
the various α-syns (WT, A30P, or A53T), pregrowing cells in 
noninducing media to mid-log phase, and shifting cells to in-
ducing media for 3 h. The α-factor pheromone (5–10 μM) was 
added upon the shift into inducing media; the DHR 123 dye was 
added after 2 h in inducing media; and the images were ac-
quired after 3 h in inducing media. The α-factor had no effect 
on ROS accumulation in cells expressing WT α-syn (or A53T), 
as judged by red fl  uorescence (Fig. 8, B and E). In contrast, in 
identically treated cells expressing A30P α-factor decreased the 
percentage of red staining A30P-expressing cells to 26.3 ± 
4.2% from 69.2 ± 8.5% (P = 1.1 × 10
−7) (Fig. 8, C and E). No 
appreciable amounts of ROS occurred in vector control cells 
with or without pheromone (Fig. 8 D). Our interpretation of 
these results was that pheromone triggered rapid RME, and 
because of Ypp1p’s ability to bind A30P at the plasma membrane, 
A30P was encapsulated into the endocytic vesicles, which then 
traffi  cked to the vacuole.
Discussion
The biochemical, cell biological, and genetic experiments in 
this study have demonstrated a role for the essential gene YPP1 
in endocytosis. We conducted a PSI-blast analysis of YPP1, 
 using  the  Saccharomyces Genome Database, and found six 
  potential functional homologues (orthologues) in humans. One 
of these, human TTC7B (Q86TV6), has 15% identical residues 
with YPP1. The TTC7B protein contains multiple tetratrico-
peptide repeat (TPR) protein–protein interaction domains (Lamb 
et al., 1995), and it is likely that the Ypp1 protein also contains 
such domains. Other than TPR domains, Ypp1p has no rec-
ognizable domains. Next, several issues are discussed relating 
to the role of Ypp1p in endocytosis and protection it affords 
against A30P.
Notice that A30P expression in the pep4∆ strain with 
YPP1 in high copy caused no appreciable toxicity, as judged by 
ROS accumulation (Fig. 6). We propose that YPP1 in high 
copy, whether in WT cells or pep4∆ cells, mediates the trans-
port of A30P to vacuole. The lack of toxicity of A30P in pep4∆ 
cells with YPP1 in high copy is due to the removal of A30P 
from the plasma membrane and cytosol and sequestration in 
vacuoles. Suppression of A30P toxicity could be linked more to 
its sequestration in the vacuole rather than its degradation.
If Ypp1p functions in the endocytic pathway, why does 
Ypp1p select A30P, which appears to be a cytosolic protein, 
and target it to the vacuole instead of WT α-syn or A53T, which 
are membrane bound? Points addressing the selectivity of 
Ypp1p for A30P are: (1) A30P is not only a cytosolic protein; it 
also associates with membranes, albeit not as strongly as WT 
α-syn or A53T, and permeablizes the membranes to which it 
binds (Lashuel et al., 2002; Furukawa et al., 2006). Therefore, 
membrane-associated A30P should be able to associate with 
membrane-associated Ypp1p. (2) When overexpressed, Ypp1p 
rapidly packaged each of the α-syns (WT, A30P, and A53T) 
into inclusions/vesicles, albeit only A30P-containing vesicles 
then merged with the vacuole (Fig. 3, Fig. 4 A, and Fig. 5). The 
transport of A30P-containing vesicles to the vacuole is no doubt 
casually connected to the binding of A30P to Ypp1p. Such 
results suggest two separable functions for Ypp1p. The in-
complete endocytosis of WT and A53T α-syn—which is pro-
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accumulation of Lewy body–like structures. (3) It is important 
to recognize that a spectrum of protein–protein equilibrium 
constants, from nanomolar to micromolar, occurs in cells. 
Ypp1p may weakly associate with WT α-syn or A53T, but the 
short-lived complexes cannot be pulled out of solution. The 
A→P substitution could increase the strength of the association 
between α-syn and Ypp1p for many reasons. We reason that, 
compared with WT α-syn and A53T, A30P may adopt a differ-
ent conformation when membrane bound, it may possess a dif-
ferent phosphorylation pattern, and it may be ubiquitinylated at 
a different site. These unique features could foster a strong 
association between A30P and Ypp1p, resulting in kinetically 
stable complexes that can be pulled out of solution.
WT α-syn and the A53T mutant cause ER stress (Gosavi 
et al., 2002; Smith et al., 2005; Cooper et al., 2006), and, above 
a certain threshold concentration, each protein inhibits forward 
vesicle transport through the ER (Cooper et al., 2006). Alleles 
that suppress α-syn toxicity (WT and A53T) enhance forward 
ER-Golgi transport, and these suppressors are YPT1,  YKT6, 
UBP3 and BRE5, and ERV29. YPP1 in high copy failed to sup-
press the toxicity of WT α-syn and A53T, thus YPP1 does not 
enhance forward ER-Golgi traffi  c vis-à-vis these two α-syns. 
Regarding A30P, A30P has not been shown to cause ER stress 
or inhibit ER-Golgi traffi  c, and our experiments gave no indica-
tion that YPP1 enhances the forward transport of A30P through 
the ER-Golgi (Fig. 7, F and G).
In summary, YPP1 interacts with the evolutionarily con-
served genes SLA1, SLA2, END3, class E VPS, and CCZ1 and 
MON1 to target A30P α-syn to the vacuole for degradation via 
the endocytic pathway (Fig. 9). It will be of interest to charac-
terize the step or steps that Ypp1p catalyzes in the endocytic 
pathway, correlate Ypp1p structure with function, and determine 
whether the potential human orthologues mediate the traffi  cking 
of A30P to the lysosome in human cells.
Figure 8. Pheromone protects cells from 
A30P toxicity. (A) Effect of α-factor on cells 
expressing Ypp1p-GFP. Top (−α-factor): no 
change in the localization of Ypp1p-GFP oc-
curred over 20 min. Bottom (+α-factor): 10 μM 
α-factor was added to cells and then images 
were acquired from 2 to 20 min. Strain: YPP1-
GFP cultured in YPD. Identical instrumental 
conditions were used for all images. Bar, 5 μm. 
The ROS assay using the DHR 123 dye is 
shown in (B) WT α-syn, (C) A30P, and (D) vec-
tor control. The FY23 strain was transformed 
with pTF201 (WT α-syn), pTF202 (A30P), 
pTF203 (A53T), or pTF200 (empty vector) and 
pregrown in noninducing media to mid-log 
phase. 10 μM pheromone was added after 
shifting to inducing media; after 2 h in induc-
ing media the DHR 123 dye was added to 
5 μg/ml; and, before acquiring images at 3 h, 
cells were washed and resuspended in induc-
ing media. The two images labeled “MERGE” 
(in A) had brightness and contrast adjustments 
of +10 and +40, respectively. (E) Plot of mean 
ROS (%) (± SD). Cells (n = 292–696) were 
counted in two independent experiments. *, P = 
1.1 × 10
−7. DIC, differential interference con-
trast; DHR, rhodamine 123.SUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1101
Materials and methods
Strains, plasmids, and media
The yeast strains used in this study were FY23 (Winston et al., 1995), 
S288c (Invitrogen), YPP1-GFP (Invitrogen), which contains an integrated 
copy of YPP1-GFP replacing the WT allele, and several strains from the 
Hughes collection (Open Biosystems) (Table I). Additionally, 116 strains 
from the ResGen deletion collection were also used; these strains were de-
rived from the parental strain S288c. Cells transformed with various plas-
mids were pregrown in synthetic sucrose (2% wt/vol) drop out media to 
maintain selection for plasmids. Media containing sucrose is referred to as 
noninducing media. α-Syn expression, as well as Ypp1p overexpression, 
was induced in the same drop out media with galactose (2% wt/vol) 
replacing sucrose (Burke et al., 2000). Media containing galactose is re-
ferred to as inducing media. The various S288c deletion strains were 
cultured in noninducing media with selection for plasmids supplemented 
with 0.4 g/L G418 (Geneticin) or inducing media with selection for plasmids 
supplemented with 0.4 g/L G418. The Resgen deletion strains (Invitrogen) 
and the high copy yeast genomic library (Nasmyth and Tatchell, 1980) 
(YEp13 LEU2) were gifts from Dr. Kelly Tatchell (LSU Health Sciences 
Center, Shreveport, LA). In every experiment in this study, cells were pre-
grown in noninducing media (sucrose) with selection for plasmids to mid-log 
phase and then shifted to inducing media (galactose) with selection for 
plasmids and induced for 3 h. In some cases, 12-h inductions were used. 
Cells were grown at 30°C.
YPP1 was cloned from genomic DNA using the forward and reverse 
primers 5′-C  C  A  C  T  G  G  A  T  C  C  A  T  G  C  C  T  A  A  C  T  C  A  A  A  T  G  T  T  C  -3′ and 5′-G  A  A-
G  A  A  G  A  G  C  T  C  T  T  A  G  T  A  A  TT  C  G  A  A  T  A  C  C  T  T  A  G  -3′, respectively. These prim-
ers contained the BamHI and SacI restriction sites. The PCR product was 
subcloned into the BamHI and SacI restriction sites on the 2-μm pRS326 
plasmid. For all other YPP1 constructs, the YPP1 ORF was excised from the 
pRS326 plasmid at the BamHI and SacI sites and ligated into those same 
sites in the other plasmids. Preparation of the plasmids harboring untagged 
and GFP-tagged α-syns was described elsewhere (Flower et al., 2005). 
MON1 was cloned from genomic DNA using the forward and reverse prim-
ers 5′-C  A  T  A  G  A  C  G  G  G  C  C  G  C  A  T  G  G  G  T  C  T  A  G  C  T  T  A  A  A  T  A  C  -3′ and 5′-A  A  C-
C  T  C  G  A  G  C  T  C  A  C  AA  G  T  T  A  A  A  A  C  A  C  G  G  C  C  -3′, respectively. These primers 
contained the NotI and SacI restriction sites; the PCR product was subcloned 
into the same restriction sites on the low copy pRS313 plasmid. SLA1 was 
cloned from genomic DNA using the forward and reverse primers 5′-C  A  G-
G  T  G  A  C  T  A  G  T  G  A  A  G  T  A  G  G  C  C  A  T  T  C  A  C  T  G  C  -3′ and 5′-T  C  T  T  A  A  C  C  G  C  G  G  T-
T  A  A  T  C  T  A  G  A  A  T  C  C  A  A  A  C  G  G  A  T  T  T  T  G  -3′ These primers contained SpeI and 
SacII restriction sites; the PCR product was subcloned into the same restric-
tion sites on the low copy pRS313 plasmid. Plasmids were propagated 
according to standard protocols using Escherichia coli DH5α (Sambrook 
et al., 1989).
Yeast α-factor pheromone (Zymo Research) was aliquoted into cells 
from a stock solution; the ﬁ  nal concentration of α-factor was 5–10 μM. 
  Latrunculin A, cycloheximide, and the proteasome inhibitor MG132 were 
purchased form Sigma-Aldrich and used at concentrations of 25, 10, and 
50  μM, respectively. For the ROS experiments that used pheromone, 
FY23 cells transformed with the various plasmids for α-syn (pTF200-203) 
were pregrown in noninducing media to mid-log phase and then shifted 
into inducing media. Upon the shift into inducing media the α-factor phero-
mone was added to 5–10 μM. After 2 h in inducing media with phero-
mone the DHR 123 dye was added to a ﬁ  nal concentration of 5 μg/ml, 
and cells were incubated 1 additional hour in this media. Before image 
acquisition (after 3 h in inducing media) cells were washed and resus-
pended in fresh media.
Hydrogen peroxide–based genetic screen
Cells transformed with pTF202 (A30P) and the high copy yeast genomic 
  library and induced with galactose were grown to 1.5 × 10
7 cells/ml and 
then plated on SGal−Leu−Trp. A disk of sterile Whatman ﬁ  lter paper con-
taining 10 μl of 8% H2O2 was placed in the center of each plate, and 
plates were incubated for 3 d. Colonies growing close to the peroxide 
disk were selected, cultured overnight, and the plasmid DNA was isolated 
and then ampliﬁ  ed in DH5α cells. Plasmids were retested for protection in 
the hydrogen peroxide assay. Each strand of a protective plasmid was 
  sequenced. YPP1 was discovered by this approach.
Western blot analysis
Westerns were conducted as described previously (Flower et al., 2005). 
The monoclonal antibody against human α-syn was purchased from 
Cell Signaling Technologies. The monoclonal antibody against Pgk1p 
was purchased from Invitrogen. The monoclonal antibody against myc 
was purchased from Sigma-Aldrich. Secondary antibodies were pur-
chased from Sigma-Aldrich or Bio-Rad Laboratories. 20 μg of protein 
were loaded per well in each Western blot conducted (Fig. 1 B, Fig. 2 E, 
and Fig. 4 B).
Coimmunoprecipitation
The coimmunoprecipitation was performed using protein A–Sepharose beads 
saturated with the anti-myc antibody as described in Flower et al. (2005).
Fluorescence microscopy
Fluorescent images of cells were obtained with a microscope (AX70; 
Olympus), including an Olympus UPlanFl 100×/1.35 NA objective with 
CoolSNAP HQ CCD camera (Roper Scientiﬁ  c). The acquisition software 
was IPLab v3.6 (Scanalytics). An Olympus U-MWG (510–550) ﬁ  lter set was 
used for detecting GFP (Figs. 3, 7, and 8), and a U-MNG ﬁ  lter (530–550 nm) 
was used to detect FM4-64, DHR 123, and FUN1 (Figs. 1, 2, 4, and 8; 
and Fig. S2). For the two-color experiment (Fig. 1 C and Fig. 4), a more 
restrictive Chroma JP1 (510 nm) was used to detect GFP; this ﬁ  lter set 
prevented bleed-through of GFP signal into the FM4-64 channel. All data 
were collected at room temperature.
The ROS assay, using the DHR 123 dye, was performed as de-
scribed previously (Flower et al., 2005). The viability assay, using the 
FUN1 dye, was conducted according to Fannjiang et al. (2004). Vacuole 
staining, using the FM4-64 dye, was conducted according to a method 
adapted from Vida and Emr (1995). In brief, S288c cells transformed with 
a GFP-α-syn plasmid (pTF305-308) and with a YPP1 plasmid (pTF602) 
were pregrown in SSuc−Leu−Ura to mid-log phase. Cells were then 
washed and resuspended in SGal−Leu−Ura and induced for 12 h at 
30°C. At various times aliquots were removed, washed, resuspended in 
YPD, and incubated with 40 μM FM4-64 (Invitrogen) for 10 min at 30°C. 
Cells were then washed twice, resuspended in YPD, incubated an addi-
tional 30 min at 30°C, and visualized by ﬂ  uorescence microscopy. Adobe 
Photoshop 5.5 was used to prepare all ﬁ  gures. Adjustments in contrast 
were made to Westerns blots. Adjustments in brightness and contrast were 
made to some differential interference contrast (DIC) images and to some 
merged images (DIC merged with GFP ﬂ  uorescence). Speciﬁ  c adjustments 
are given in the legends.
Figure 9. Illustration  of  YPP1-mediated protection against A30P. Sla1p, 
Sla2p, and End3p form complexes at the actin cortical patches. Ypp1p 
binds to A30P and mediates the encapsulation of A30P into vesicles, which 
then bud off the membrane and transit to the vacuole. Class E Vps proteins 
are required for protein sorting into lumenal vesicles. The Mon1p–Ccz1p 
complex facilitates vesicle–vacuole fusion. MVB, multivesicular body.JCB • VOLUME 177 • NUMBER 6 • 2007  1102
Transmission electron microscopy
TEM samples were prepared as described previously (Yang et al., 2006) 
and examined using an electron microscope (H-7000; Hitachi), equipped 
with a high-resolution digital camera (Gatan, Inc.). For immunogold label-
ing, cells were ﬁ  xed with 4% formaldehyde and 0.25% glutaraldehyde in 
40 mM phosphate buffer (pH 6.7), containing 1 mM MgCl2 and 1 mM 
EGTA for 1 h at room temperature. Cells were washed with phosphate 
buffer, incubated in 1% sodium metaperiodate for 15 min, then in 50 mM 
ammonium chloride for 15 min. Cells were dehydrated with graded ethanol, 
embedded in LR White resin (Electron Microscopy Sciences). 60-nm-thin 
sections were cut and collected on nickel grids. Grids were incubated in 
0.1 M glycine in PBS containing 0.1% (vol/vol) Triton X-100 for 15 min to 
inactivate residual aldehydes. Sections were blocked with blocking buffer 
(PBS containing 5% normal goat serum, 0.2% Tween 20, and 0.2% BSA) 
for 40 min. Grids were then incubated in the primary rabbit anti-A30P 
  antibody, diluted 1:50 in blocking buffer for 2 h. Grids were washed then 
incubated in 12-nm gold–conjugated goat anti–rabbit IgG (Jackson Immuno-
Research Laboratories) diluted 1:30 in blocking buffer for 1.5 h. Labeled 
sections were stained with 2% uranyl acetate for 30 min and lead citrate 
for 30 s, examined as described above. The control was performed by 
substituting primary antibody with blocking buffer.
ROS plate reader assay
A Perkin Elmer Wallac Victor
3 1420 multilabel counter was used to screen 
deletion strains for ROS accumulation. Cells transformed with the pTF302 
(A30P) and pTF602 (YPP1) plasmids were pregrown in noninducing me-
dia until mid-log phase and then shifted into galactose inducing media and 
induced for 3 h. After the second hour of induction, the DHR 123 dye was 
added to a ﬁ  nal concentration of 5 μg/ml. Before adding the cells to the 
96-well plates, cells were washed twice using PBS and the assay was con-
ducted in PBS. The excitation and emission wavelengths were 485 and 
535 nm, respectively. At minimum, deletion strains were analyzed in two 
independent experiments in triplicate. Thirty of the deletion strains were 
analyzed in three to four independent experiments in triplicate. ROS read-
ings from each deletion strain were compared with the ROS readings from 
the S288c strain (transformed with pTF302 [A30P] and pTF602 [YPP1]). 
Acetic acid treatment has been shown to induce apoptosis and ROS in 
yeast cells (Ludovico et al., 2002), and acetic acid–treated cells were pre-
pared and incubated with DHR 123 as described previously (Flower et al., 
2005) as a control.
Deletion strains exhibiting greater than fourfold increases in ROS 
signal compared with the control (S288c transformed with pTF202 and 
pTF602) were selected for further evaluation. One two-plasmid control con-
sisted of the various deletion strains expressing Ypp1p (pTF602 (YPP1) plus 
pTF300 (empty vector)). The other two-plasmid controls consisted of the 
various deletion strains harboring plasmids with no inserts (pTF300 and 
pTF604). ROS accumulation was measured after 3 h of induction. Ypp1p 
overexpression did not appreciably increase the ROS signal, and the two-
plasmid control cells yielded a signal indicative of zero ﬂ  uorescence.
Statistical analysis
For the ROS (and FUN1 viability assays) (Figs. 1 and 8, and Fig. S2), 
P values were determined using a two-tailed t test (heteroscedastic) that 
compared red cell counts from various +α-syn/+Ypp1 cultures to red cell 
Table I. Yeast strains and plasmids
Strains
YPP1-GFP  his3∆1 leu2∆0 met15∆0 ura3∆0 YPP1-GFP MATa
FY23 ura3-52 trp1∆63 leu2∆ 1 MATa
S288c his3∆1 leu2∆0 met15∆0 ura3∆0 gal2 MATα
Tet-YPP1 pYGR198W::kanR-tet07-TATA URA3::CMV-tTA his3-1 leu2-0 met15-0 MATa
Tet-SEC1 pSEC1::kanR-tet07-TATA URA3::CMV-tTA his3-1 leu2-0 met15-0 MATa
Tet-SEC5 pSEC5::kanR-tet07-TATA URA3::CMV-tTA his3-1 leu2-0 met15-0 MATa
Tet-SEC12 pSEC12::kanR-tet07-TATA URA3::CMV-tTA MATa his3-1 leu2-0 met15-0 MATa
Plasmids
pRS313 Low copy CEN HIS3 ARS Amp
r ATCC
pRS314 Low copy CEN TRP1 ARS Amp
r ATCC
pRS316 Low copy CEN URA3 ARS Amp
r ATCC
pRS326 2 μ URA3 Amp
r  (Christianson et al., 1992)
pRS325 2 μ LEU2 Amp
r (Christianson et al., 1992)
pTF200 GAL1 promoter in pRS314 (Flower et al., 2005)
pTF201  GAL1 promoter WT α-syn in pRS314 (Flower et al., 2005)
pTF202  GAL1 promoter A30P α-syn in pRS314  (Flower et al., 2005)
pTF203  GAL1 promoter A53T α-syn in pRS314  (Flower et al., 2005)
pTF300  GAL1 promoter in pRS316  (Flower et al., 2005)
pTF301  GAL1 promoter WT α-syn in pRS316  (Flower et al., 2005)
pTF302  GAL1 promoter A30P α-syn in pRS316  (Flower et al., 2005)
pTF303  GAL1 promoter A53T α-syn in pRS316  (Flower et al., 2005)
pTF305  GAL1 promoter GFP-WT α-syn in pRS316 This study
pTF306  GAL1 promoter GFP-A30P in pRS316 This study
pTF307  GAL1 promoter GFP-A53T in pRS316 This study
pTF308 GAL1 promoter GFP in pRS316 This study
pTF503 GAL1 promoter cMyc (9 repeats) in pRS326 This study
pTF504  GAL1 promoter cMyc (9 repeats) YPP1 in pRS326 This study
pTF601  GAL1 promoter YPP1 in pRS326  This study
pTF602  GAL1 promoter YPP1 in pRS325 This study
pTF603 GAL1 promoter in pRS326  This study
pTF604 GAL1 promoter in pRS325 This study
pTF700 GAL1 promoter MON1 in pRS313 This study
pTF701 GAL1 promoter SLA1 in pRS313 This studySUPPRESSION OF A30P α-SYN TOXICITY BY YPP1 • FLOWER ET AL. 1103
counts from various +α-syn/−Ypp1 cultures. Cells were counted in two 
to three independent experiments. The program Excel was used for this 
analysis. For the ROS plate reader assay (Fig. 6), a paired t test was used 
to compare the ROS signals from deletion strains to matched controls 
(S288c +A30P/+YPP1). To adjust for multiple comparisons, the Bonferroni 
correction method was used, with a family-wise error rate of 0.05 or 0.001. 
For example, because 116 gene deletion strains were tested, the highest 
accepted P value was 4.3 × 10
−4 (= 0.05/116) for a family error rate of 
0.05. The statistical software used for this analysis was SAS v9.13 (SAS 
Institute, Inc.). Table S1 gives exact P values (available at http://www.jcb
.org/cgi/content/full/jcb.200610071/DC1).
Online supplemental material
Fig. S1 shows that in high copy YPP1 permitted normal growth of cells ex-
pressing A30P, but not of cells expressing WT or A53T. Fig. S2 shows that 
YPP1 in high copy fails to protect cells from hydrogen peroxide–  induced 
ROS. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200610071/DC1.
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